123 related articles for article (PubMed ID: 2680697)
1. Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.
Hartmann H; Oberhaus K; Spahr R; Brandenburg D; Creutzfeldt W; Probst I
Diabetologia; 1989 Jul; 32(7):416-20. PubMed ID: 2680697
[TBL] [Abstract][Full Text] [Related]
2. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like action of proinsulin on rat liver carbohydrate metabolism in vitro.
Probst I; Hartmann H; Jungermann K; Creutzfeldt W
Diabetes; 1985 May; 34(5):415-9. PubMed ID: 3886457
[TBL] [Abstract][Full Text] [Related]
4. Acute metabolic actions of des-(B27-B30)-insulin and related analogues in adult rats.
Hartmann H; Korf J; Ottmers U; Creutzfeldt W
Acta Diabetol; 1993; 30(2):108-14. PubMed ID: 8219258
[TBL] [Abstract][Full Text] [Related]
5. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
[TBL] [Abstract][Full Text] [Related]
6. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
7. Metabolic actions of insulin-like growth factor-I in cultured hepatocytes from adult rats.
Hartmann H; Schmitz F; Christ B; Jungermann K; Creutzfeldt W
Hepatology; 1990 Nov; 12(5):1139-43. PubMed ID: 2227811
[TBL] [Abstract][Full Text] [Related]
8. Shortened insulin with enhanced in vitro potency.
Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
[TBL] [Abstract][Full Text] [Related]
9. Metabolic actions of insulin-like growth factor II in cultured adult rat hepatocytes are not mediated through the insulin-like growth factor II receptor.
Hartmann H; Meyer-Alber A; Braulke T
Diabetologia; 1992 Mar; 35(3):216-23. PubMed ID: 1348710
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by recombinant human interleukin-6 of the glucagon-dependent induction of phosphoenolpyruvate carboxykinase and of the insulin-dependent induction of glucokinase gene expression in cultured rat hepatocytes: regulation of gene transcription and messenger RNA degradation.
Christ B; Nath A; Heinrich PC; Jungermann K
Hepatology; 1994 Dec; 20(6):1577-83. PubMed ID: 7527006
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
12. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
[TBL] [Abstract][Full Text] [Related]
13. A shortened insulin with full in vitro potency.
Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
[TBL] [Abstract][Full Text] [Related]
14. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
Nakagawa SH; Tager HS
J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
[TBL] [Abstract][Full Text] [Related]
15. Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes.
Iynedjian PB; Marie S; Gjinovci A; Genin B; Deng SP; Buhler L; Morel P; Mentha G
J Clin Invest; 1995 May; 95(5):1966-73. PubMed ID: 7738162
[TBL] [Abstract][Full Text] [Related]
16. Comparison of subcutaneously administered soluble insulin and des-(B26-B30)-insulin-B25-amide in rabbit, pig and healthy man.
Hartmann H; Moesus E; Creutzfeldt W
Diabetes Res Clin Pract; 1992 Jun; 16(3):175-81. PubMed ID: 1425137
[TBL] [Abstract][Full Text] [Related]
17. Insulin-mimetic actions of phorbol ester in cultured adult rat hepatocytes. Lack of phorbol-ester-elicited inhibition of the insulin signal.
Quentmeier A; Daneschmand H; Klein H; Unthan-Fechner K; Probst I
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):549-55. PubMed ID: 8380998
[TBL] [Abstract][Full Text] [Related]
18. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
Schwartz GP; Burke GT; Katsoyannis PG
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):458-61. PubMed ID: 2643113
[TBL] [Abstract][Full Text] [Related]
19. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
20. Permissive action of triiodothyronine on the long-term increase of glycolysis by insulin in cultured rat hepatocytes.
Rosa J; Probst I; Jungermann K
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):997-1003. PubMed ID: 3067734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
